Table I.
Author | Year [Reference] | # patients | Recurrence (%) | Secondary stroke rate per 100 patient-years |
---|---|---|---|---|
Observation alone | ||||
Powars et al. | 1980 [19] | 19 | 63 | 13 |
Moohr et al. | 1982 [20] | 14 | 83 | 54 |
Russell et al. | 1984 [21] | 10 | 90 | 108 |
Balkaran et al. | 1992 [22] | 15 | 47 | 25 (estimated) |
Chronic transfusions | ||||
Moohr et al. | 1982 [20] | 7 | 0 | 0 |
Russell et al. | 1984 [21] | 20 | 14 | 2.0 (estimated) |
Pegelow et al. | 1995 [23] | 61 | 15 | 4.8 |
Ohene-Frempong et al. | 1998 [2] | 72 | 14 | 6.4 |
Scothorn et al. | 2002 [24] | 137 | 23 | 2.2 |
Ware et al. | Unpublished | 44 | 11 | 3.3 |
Transfusion discontinuation | ||||
Wilimas et al. | 1980 [4] | 10 | 70 | Unavailable |
Moohr et al. | 1982 [20] | 7 | 14 | 10 |
Wang et al. | 1991 [5] | 10 | 50 | 51 (estimated) |
Rana et al. | 2001 [25] | 9 | 0 | 0 |
Change from transfusions to hydroxyurea prophylaxis | ||||
Ware et al. * | 1999 [15] | 15 | 33 | 6.8 |
Ware et al. † | 2004 [16] | 21 | 10 | 3.1 |
Ware et al. # | 2004 [16] | 36 | 19 | 5.0 |
subjects who had an abrupt discontinuation of transfusions,
subjects with an overlap period of transfusions and hydroxyurea, and
all subjects who switched from chronic transfusions to hydroxyurea therapy for secondary stroke prophylaxis.